• Tue. Dec 1st, 2020

Pharma Oracle

Evolving Today for better Tomorrow

Oxford will study top-selling prescription drug for potential COVID-19 treatment

ByRenita Lyon

Sep 30, 2020
Oxford will study top-selling prescription drug for potential COVID-19 treatment

LONDON (Reuters) – Britain’s Oxford University said on Wednesday it would study whether the world’s best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients, the latest effort to repurpose existing drugs as potential coronavirus therapies.

The AVID-CC trial will test the anti-tumour necrosis factor (anti-TNF) drug and will be aimed at treating people in the community, especially in care homes. It will enrol up to 750 patients from community care settings throughout the UK.

Reporting by Josephine Mason and Kate Kelland; Editing by Gareth Jones

Leave a Reply

Your email address will not be published. Required fields are marked *